Obesity and... Liver Disease

We will be exploring the critical connection between obesity and liver disease, specifically MASLD (Metabolic dysfunction-associated steatotic liver disease) and MASH (Metabolic dysfunction-associated steatohepatitis). With obesity now recognised as a major driver of liver conditions, we’ll unpack the importance of clear, accessible language for patients, and why health literacy isn’t just a “nice-to-have” but essential to effective care. Our discussions will also highlight the persistent stigma surrounding both obesity and liver disease, and how this impacts diagnosis, treatment, and trust in healthcare.Whether you’re a healthcare provider, patient advocate, or someone living with obesity or liver disease, this conversation is a call to action for better understanding, better communication, and better care.